208 related articles for article (PubMed ID: 36472194)
1. Device-Sizing and Associated Complications With Left Atrial Appendage Occlusion: Findings From the NCDR LAAO Registry.
Sandhu A; Varosy PD; Du C; Aleong RG; Tumolo AZ; West JJ; Tzou WS; Curtis JP; Freeman JV; Friedman DJ; Hess PL
Circ Cardiovasc Interv; 2022 Dec; 15(12):e012183. PubMed ID: 36472194
[TBL] [Abstract][Full Text] [Related]
2. Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry.
Price MJ; Valderrábano M; Zimmerman S; Friedman DJ; Kar S; Curtis JP; Masoudi FA; Freeman JV
Circ Cardiovasc Interv; 2022 May; 15(5):e011718. PubMed ID: 35369701
[TBL] [Abstract][Full Text] [Related]
3. Comparative Safety of Transcatheter LAAO With the First-Generation Watchman and Next-Generation Watchman FLX Devices.
Price MJ; Friedman DJ; Du C; Wang Y; Lin Z; Curtis JP; Freeman JV
JACC Cardiovasc Interv; 2022 Nov; 15(21):2115-2123. PubMed ID: 36357014
[TBL] [Abstract][Full Text] [Related]
4. Procedure Volume and Outcomes With WATCHMAN Left Atrial Appendage Occlusion.
Friedman DJ; Du C; Zimmerman S; Tan Z; Lin Z; Vemulapalli S; Kosinski AS; Piccini JP; Pereira L; Minges KE; Faridi KF; Masoudi FA; Curtis JP; Freeman JV
Circ Cardiovasc Interv; 2024 Jun; 17(6):e013466. PubMed ID: 38889251
[TBL] [Abstract][Full Text] [Related]
5. One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices.
Mansour MJ; Harnay E; Al Ayouby A; Mansourati V; Jobic Y; Gilard M; Le Ven F; Mansourati J
J Interv Card Electrophysiol; 2022 Jun; 64(1):27-34. PubMed ID: 34002319
[TBL] [Abstract][Full Text] [Related]
6. Clinical Impact of Residual Leaks Following Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry.
Alkhouli M; Du C; Killu A; Simard T; Noseworthy PA; Friedman PA; Curtis JP; Freeman JV; Holmes DR
JACC Clin Electrophysiol; 2022 Jun; 8(6):766-778. PubMed ID: 35387751
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography measurement of the left atrial appendage for optimal sizing of the Watchman device.
Xu B; Betancor J; Sato K; Harb S; Abdur Rehman K; Patel K; Kumar A; Cremer PC; Jaber W; Rodriguez LL; Schoenhagen P; Wazni O
J Cardiovasc Comput Tomogr; 2018; 12(1):50-55. PubMed ID: 29223726
[TBL] [Abstract][Full Text] [Related]
8. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
9. Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease.
Raghuram P; Pavithran S; Sivakumar K
Indian Heart J; 2020; 72(5):369-375. PubMed ID: 33189196
[TBL] [Abstract][Full Text] [Related]
10. Sex Differences in Procedural Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry.
Darden D; Duong T; Du C; Munir MB; Han FT; Reeves R; Saw J; Zeitler EP; Al-Khatib SM; Russo AM; Minges KE; Curtis JP; Freeman JV; Hsu JC
JAMA Cardiol; 2021 Nov; 6(11):1275-1284. PubMed ID: 34379072
[TBL] [Abstract][Full Text] [Related]
11. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.
Reddy VY; Holmes D; Doshi SK; Neuzil P; Kar S
Circulation; 2011 Feb; 123(4):417-24. PubMed ID: 21242484
[TBL] [Abstract][Full Text] [Related]
12. Sex Differences in Safety and Effectiveness of LAAO: Insights From the Amulet IDE Trial.
Alkhouli M; Russo AM; Thaler D; Windecker S; Anderson JA; Gage R; Lakkireddy D
JACC Cardiovasc Interv; 2022 Nov; 15(21):2143-2155. PubMed ID: 36357018
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion.
Simard T; Jung RG; Lehenbauer K; Piayda K; Pracoń R; Jackson GG; Flores-Umanzor E; Faroux L; Korsholm K; Chun JKR; Chen S; Maarse M; Montrella K; Chaker Z; Spoon JN; Pastormerlo LE; Meincke F; Sawant AC; Moldovan CM; Qintar M; Aktas MK; Branca L; Radinovic A; Ram P; El-Zein RS; Flautt T; Ding WY; Sayegh B; Benito-González T; Lee OH; Badejoko SO; Paitazoglou C; Karim N; Zaghloul AM; Agrawal H; Kaplan RM; Alli O; Ahmed A; Suradi HS; Knight BP; Alla VM; Panaich SS; Wong T; Bergmann MW; Chothia R; Kim JS; Pérez de Prado A; Bazaz R; Gupta D; Valderrabano M; Sanchez CE; El Chami MF; Mazzone P; Adamo M; Ling F; Wang DD; O'Neill W; Wojakowski W; Pershad A; Berti S; Spoon D; Kawsara A; Jabbour G; Boersma LVA; Schmidt B; Nielsen-Kudsk JE; Rodés-Cabau J; Freixa X; Ellis CR; Fauchier L; Demkow M; Sievert H; Main ML; Hibbert B; Holmes DR; Alkhouli M
J Am Coll Cardiol; 2021 Jul; 78(4):297-313. PubMed ID: 34294267
[TBL] [Abstract][Full Text] [Related]
14. Impact of Preprocedure Imaging for Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry.
Clarke JD; Higgins AY; Wang Y; Faridi KF; Curtis JA; Freeman JV; Friedman DJ
JACC Cardiovasc Interv; 2023 Jun; 16(11):1317-1328. PubMed ID: 37316143
[TBL] [Abstract][Full Text] [Related]
15. The NCDR Left Atrial Appendage Occlusion Registry.
Freeman JV; Varosy P; Price MJ; Slotwiner D; Kusumoto FM; Rammohan C; Kavinsky CJ; Turi ZG; Akar J; Koutras C; Curtis JP; Masoudi FA
J Am Coll Cardiol; 2020 Apr; 75(13):1503-1518. PubMed ID: 32238316
[TBL] [Abstract][Full Text] [Related]
16. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
[TBL] [Abstract][Full Text] [Related]
17. Indications for Left Atrial Appendage Occlusion in the United States and Associated In-Hospital Outcomes: Results From the NCDR LAAO Registry.
Daimee UA; Wang Y; Masoudi FA; Varosy PD; Friedman DJ; Du C; Koutras C; Reddy VY; Saw J; Price MJ; Kusumoto FM; Curtis JP; Freeman JV
Circ Cardiovasc Qual Outcomes; 2022 Aug; 15(8):e008418. PubMed ID: 35959677
[TBL] [Abstract][Full Text] [Related]
18. Catheter Ablation for Atrial Fibrillation in Patients With Watchman Left Atrial Appendage Occlusion Device: Results from a Multicenter Registry.
Turagam MK; Lavu M; Afzal MR; Vuddanda V; Jazayeri MA; Parikh V; Atkins D; Bommana S; DI Biase L; Horton R; Bai R; Swarup V; Cheng J; Natale A; Lakkireddy D
J Cardiovasc Electrophysiol; 2017 Feb; 28(2):139-146. PubMed ID: 27943538
[TBL] [Abstract][Full Text] [Related]
19. Intracardiac versus transesophageal echocardiography for left atrial appendage occlusion with watchman.
Frangieh AH; Alibegovic J; Templin C; Gaemperli O; Obeid S; Manka R; Holy EW; Maier W; Lüscher TF; Binder RK
Catheter Cardiovasc Interv; 2017 Aug; 90(2):331-338. PubMed ID: 27649848
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous left atrial appendage occlusion using different technologies in the United Kingdom: A multicenter registry.
Betts TR; Leo M; Panikker S; Kanagaratnam P; Koa-Wing M; Davies DW; Hildick-Smith D; Wynne DG; Ormerod O; Segal OR; Chow AW; Todd D; Cabrera Gomez S; Kirkwood GJ; Fox D; Pepper C; Foran J; Wong T
Catheter Cardiovasc Interv; 2017 Feb; 89(3):484-492. PubMed ID: 27651124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
